Document is current
Any future updates will be listed below
-
Authors
Meier, Anna B. https://orcid.org/0000-0001-6307-3248
Zawada, Dorota https://orcid.org/0000-0003-1127-7980
De Angelis, Maria Teresa
Martens, Laura D. https://orcid.org/0000-0001-6520-4029
Santamaria, Gianluca https://orcid.org/0000-0001-9284-7492
Zengerle, Sophie
Nowak-Imialek, Monika
Kornherr, Jessica
Zhang, Fangfang
Tian, Qinghai
Wolf, Cordula M.
Kupatt, Christian https://orcid.org/0000-0002-3611-1218
Sahara, Makoto https://orcid.org/0000-0002-6281-5454
Lipp, Peter
Theis, Fabian J.
Gagneur, Julien https://orcid.org/0000-0002-8924-8365
Goedel, Alexander
Laugwitz, Karl-Ludwig https://orcid.org/0000-0003-4948-4846
Dorn, Tatjana
Moretti, Alessandra https://orcid.org/0000-0001-5782-7832
-
Funding
Funding for this research was provided by:
Fondazione Umberto Veronesi
Deutsche Herzstiftung e.V. Gerd-Killian Award
Deutsche Forschungsgemeinschaft (Transregio Research Unit 267, Transregio Research Unit 152, Transregio Research Unit 267, Transregio Research Unit 152, Transregio Research Unit 267, Transregio Research Unit 152, Transregio Research Unit 267)
Deutsches Zentrum für Herz-Kreislaufforschung (FKZ 81Z0600601, FKZ 81Z0600601)
- License Information
-
More Information
Article History
Received: 14 March 2022
Accepted: 22 February 2023
First Online: 3 April 2023
Competing interests
: The Technical University of Munich filed a patent application (EP 22 164 561.7) on the generation of epicardioids, with A.B.M., A.M. and K.-L.L. named as inventors. F.J.T. consults for Immunai, Inc., Singularity Bio B.V., CytoReason, Ltd., and Omniscope, Ltd., and has ownership interest in Dermagnostix GmbH and Cellarity. C.M.W. is a consultant for Day One Biopharmaceuticals, Biomarin, Adrenomed AG and Pliant Therapeutics. C.M.W. is founder/shareholder of Preventage Therapeutics. All other authors have no competing interests.
